Identifying metabolic risks with antipsychotics and monitoring and management strategies.

The Journal of clinical psychiatry

Volumn 68, Issue 7, 2007, Pages

  Newcomer, John W ^a   Sernyak, Michael J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

BODY MASS; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; DIABETES MELLITUS; DRUG EFFECT; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; REVIEW; WEIGHT GAIN;

ADIPOSITY; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; WEIGHT GAIN;

EID: 34748859111     PISSN: None     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/jcp.0707e17     Document Type: Review

References (15)